GABBR2
Gamma-aminobutyric acid type B receptor subunit 2
Also known as: GABABR2, GABR2_HUMAN, GPR51, GPRC3B, HG20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75899
- Gene
- GABBR2
- Ensembl
- ENSG00000136928
- Chromosome
- 9
- Canonical length
- 941 aa
- Protein class
- Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own. Allelic variants of this gene have been associated with nicotine dependence.[provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
941 residues, UniProt reviewed canonical sequence.
>O75899|GABBR2
1 MASPRSSGQP GPPPPPPPPP ARLLLLLLLP LLLPLAPGAW GWARGAPRPP PSSPPLSIMG
61 LMPLTKEVAK GSIGRGVLPA VELAIEQIRN ESLLRPYFLD LRLYDTECDN AKGLKAFYDA
121 IKYGPNHLMV FGGVCPSVTS IIAESLQGWN LVQLSFAATT PVLADKKKYP YFFRTVPSDN
181 AVNPAILKLL KHYQWKRVGT LTQDVQRFSE VRNDLTGVLY GEDIEISDTE SFSNDPCTSV
241 KKLKGNDVRI ILGQFDQNMA AKVFCCAYEE NMYGSKYQWI IPGWYEPSWW EQVHTEANSS
301 RCLRKNLLAA MEGYIGVDFE PLSSKQIKTI SGKTPQQYER EYNNKRSGVG PSKFHGYAYD
361 GIWVIAKTLQ RAMETLHASS RHQRIQDFNY TDHTLGRIIL NAMNETNFFG VTGQVVFRNG
421 ERMGTIKFTQ FQDSREVKVG EYNAVADTLE IINDTIRFQG SEPPKDKTII LEQLRKISLP
481 LYSILSALTI LGMIMASAFL FFNIKNRNQK LIKMSSPYMN NLIILGGMLS YASIFLFGLD
541 GSFVSEKTFE TLCTVRTWIL TVGYTTAFGA MFAKTWRVHA IFKNVKMKKK IIKDQKLLVI
601 VGGMLLIDLC ILICWQAVDP LRRTVEKYSM EPDPAGRDIS IRPLLEHCEN THMTIWLGIV
661 YAYKGLLMLF GCFLAWETRN VSIPALNDSK YIGMSVYNVG IMCIIGAAVS FLTRDQPNVQ
721 FCIVALVIIF CSTITLCLVF VPKLITLRTN PDAATQNRRF QFTQNQKKED SKTSTSVTSV
781 NQASTSRLEG LQSENHRLRM KITELDKDLE EVTMQLQDTP EKTTYIKQNH YQELNDILNL
841 GNFTESTDGG KAILKNHLDQ NPQLQWNTTE PSRTCKDPIE DINSPEHIQR RLSLQLPILH
901 HAYLPSIGGV DASCVSPCVS PTASPRHRHV PPSFRVMVSG LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GABBR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 62 nTPM
- cerebellum: 36 nTPM
- hippocampal formation: 25 nTPM
- amygdala: 24 nTPM
- hypothalamus: 19 nTPM
- midbrain: 12 nTPM
Single-cell type
- brain excitatory neurons: 372 nCPM
- retinal bipolar cells: 255 nCPM
- brain inhibitory neurons: 253 nCPM
- early spermatids: 236 nCPM
- retinal amacrine cells: 195 nCPM
- other brain neurons: 125 nCPM
Immune cell
- basophil: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- T-reg: 0.1 nTPM
Brain region
- cerebral cortex: 245 nTPM
- thalamus: 137 nTPM
- white matter: 128 nTPM
- basal ganglia: 109 nTPM
- hippocampal formation: 93 nTPM
- hypothalamus: 87 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GABBR2.
Disease | AllUniProt
Conditions GABBR2 is implicated in, by any mechanism.
- Neurodevelopmental disorder with poor language and loss of hand skills (NDPLHS) MIM:617903
- Developmental and epileptic encephalopathy 59 (DEE59) MIM:617904
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 1,171 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 59
- Neurodevelopmental disorder with poor language and loss of hand skills
- Epileptic encephalopathy
- Inborn genetic diseases
- Rett syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.63
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- chemical synaptic transmission
- G protein-coupled receptor signaling pathway
- gamma-aminobutyric acid signaling pathway
- negative regulation of adenylate cyclase activity
- neuron-glial cell signaling
- synaptic transmission, GABAergic
Molecular functions
- G protein-coupled GABA receptor activity
- protein heterodimerization activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 3
- Receptor, ligand binding region
- GPCR family 3, GABA-B receptor
- GPCR family 3, C-terminal
- GPCR, family 3, conserved site
- Periplasmic binding protein-like I
- 7 transmembrane sweet-taste receptor of 3 GCPR
- Receptor family ligand binding region
- GPCR family 3, gamma-aminobutyric acid receptor, type B2
- Gamma-aminobutyric acid type B receptor subunit 2, coiled-coil domain
- Gamma-aminobutyric acid type B receptor subunit 2 coiled-coil domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GABBR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GABBR2 as an antibody target. Whether an autoantibody or antibody against GABBR2 could matter depends on whether native GABBR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GABBR2 is annotated at the cell surface, where native GABBR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GABBR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...